Sequential Conditioning with Thiotepa in T Cell- Replete Hematopoietic Stem Cell Transplantation for the Treatment of Refractory Hematologic Malignancies: Comparison with Matched Related, Haplo-Mismatched, and Unrelated Donors-Reference-Cited by-同舟云学术

Sequential Conditioning with Thiotepa in T Cell- Replete Hematopoietic Stem Cell Transplantation for the Treatment of Refractory Hematologic Malignancies: Comparison with Matched Related, Haplo-Mismatched, and Unrelated Donors

Published:2018-05 Issue:5 Volume:24 Page:1013-1021
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Duléry Rémy,Ménard Anne-Lise,Chantepie Sylvain,El-Cheikh Jean,François Sylvie,Delage Jérémy,Giannotti Federica,Ruggeri Annalisa,Brissot Eolia,Battipaglia Giorgia,Malard Florent,Belhocine Ramdane,Sestili Simona,Vekhoff Anne,Delhommeau François,Reman Oumédaly,Legrand Ollivier,Labopin Myriam,Rubio Marie-Thérèse,Mohty Mohamad

Funder

Association for Training, Education, and Research in Hematology, Immunology, and Transplantation

Sanofi-Genzyme

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference48 articles.

1. Treatment of refractory AML;Estey;Leukemia,1996

2. Failure of three novel regimens to improve outcome for patients with relapsed or refractory acute myeloid leukaemia: a report from the Eastern Cooperative Oncology Group;Litzow;Br J Haematol,2010

3. How I treat refractory and early relapsed acute myeloid leukemia;Thol;Blood,2015

4. Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study;Fielding;Blood,2007

5. Outcome of relapsed adult lymphoblastic leukemia depends on response to salvage chemotherapy, prognostic factors, and performance of stem cell transplantation;Gökbuget;Blood,2012

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Haploidentical hematopoietic cell transplantation as a platform for natural killer cell immunotherapy;American Journal of Hematology;2024-09-09

2. Current challenges in conditioning regimens for MDS transplantation;Blood Reviews;2024-09

3. Place de l’allogreffe dans les leucémies aiguës myéloblastiques et syndromes myélodysplasiques de très haut risque (SFGM-TC);Bulletin du Cancer;2024-09

4. Treosulfan-Versus Melphalan-Based Reduced Intensity Conditioning in HLA-Haploidentical Transplantation for Patients ≥ 50 Years with Advanced MDS/AML;Cancers;2024-08-16

5. Haploidentical peripheral blood stem cell transplantation improves the survival of older patients with myeloid malignancies under low-dose antithymocyte globin (ATG)/post-cyclophosphamide (PTCy)-based regimen for graft-versus-host disease prophylaxis;2024-08-13